Finance

Beta
Lists
002566:SHE
Jilin Jian Yisheng Pharmaceutical Co Ltd
CN¥6.73
-2.46%
(-0.17) 1D
Jun 8, 3:04:30 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002566...
Open
CN¥6.81
High
CN¥6.94
Low
CN¥6.65
Mkt. cap
2.28B
Avg. vol.
6.91M
Volume
6.55M
Dividend
1.19%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
66.92
52-wk high
CN¥9.68
52-wk low
CN¥6.65
EPS
CN¥0.10
Shares outstanding
330.95M
No. of employees
2K
Open
CN¥6.81
High
CN¥6.94
Low
CN¥6.65
Mkt. cap
2.28B
Avg. vol.
6.91M
Volume
6.55M
Dividend
1.19%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
66.92
52-wk high
CN¥9.68
52-wk low
CN¥6.65
EPS
CN¥0.10
Shares outstanding
330.95M
No. of employees
2K
News stories
From sources across the web
About Jilin Jian Yisheng Pharmaceutical Co Ltd
CEO-
Employees1.62K
FoundedJun 11, 1997
Headquarters-
SectorPharmaceutical industry
Websiteyisheng-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
168.70M
148.37M
163.98M
178.61M
Cost of goods sold
41.48M
37.05M
51.97M
44.72M
Cost of revenue
41.48M
37.05M
51.97M
44.72M
Research and development expenses
4.15M
3.52M
3.58M
4.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
115.62M
97.33M
105.49M
115.30M
Operating expense
120.72M
110.81M
113.25M
125.70M
Total operating expenses
162.21M
147.86M
165.23M
170.42M
Operating income
6.49M
510.34K
-1.25M
8.19M
Other non operating income
-465.59K
393.57K
-640.61K
-39.52K
EBT including unusual items
8.16M
5.35M
2.24M
18.90M
EBT excluding unusual items
14.26M
-2.30M
-2.76M
8.20M
Income tax expense
373.57K
756.21K
-2.27M
2.68M
Effective tax rate
4.58%
14.14%
-101.06%
14.18%
Other operating expenses
598.45K
9.69M
3.89M
3.88M
Net income
6.90M
5.36M
4.87M
16.14M
Net profit margin
4.09%
3.62%
2.97%
9.04%
Earnings per share
-
-
-
-
Interest and investment income
11.53M
194.61K
1.83M
3.14M
Interest expense
-3.30M
-3.40M
-2.70M
-3.09M
Net interest expenses
8.23M
-3.20M
-871.44K
55.92K
Depreciation and amortization charges
-
-
-
-
EBITDA
16.70M
11.16M
8.38M
17.81M
Gain or loss from assets sale
-282.36K
282.36K
-400.97K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer